The number of people poisoned by the incorrect use of weight loss medication is on the rise in the Netherlands. Last year, ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

A nurse has revealed a potentially life-threatening mistake GPs could be making when prescribing revolutionary weight loss ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

The Prescription Drug User Fee Act typically calls for a period of 10 months for the FDA to review such applications, although drugs that are deemed a priority have a review period of six months.